Annual Total Long Term Liabilities
$81.31 M
+$11.23 M+16.03%
December 31, 2022
Summary
- As of February 10, 2025, KDNY annual total long term liabilities is $81.31 million, with the most recent change of +$11.23 million (+16.03%) on December 31, 2022.
- During the last 3 years, KDNY annual total long term liabilities has risen by +$26.89 million (+49.42%).
Performance
KDNY Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Long Term Liabilities
$79.30 M
-$1.22 M-1.51%
June 30, 2023
Summary
- As of February 10, 2025, KDNY quarterly total long term liabilities is $79.30 million, with the most recent change of -$1.22 million (-1.51%) on June 30, 2023.
- Over the past year, KDNY quarterly long term liabilities has increased by +$14.67 million (+22.70%).
Performance
KDNY Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
KDNY Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +16.0% | +22.7% |
| 3 y3 years | +49.4% | - |
| 5 y5 years | +49.4% | - |
KDNY Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | -13.8% | -2.5% | -18.5% |
| 5 y | 5-year | at high | -33.1% | -59.8% | -31.4% |
| alltime | all time | at high | -33.1% | -59.8% | -31.4% |
Chinook Therapeutics Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2023 | - | $79.30 M(-1.5%) |
| Mar 2023 | - | $80.52 M(-1.0%) |
| Dec 2022 | $81.31 M(+16.0%) | $81.31 M(+14.6%) |
| Sep 2022 | - | $70.96 M(+9.8%) |
| Jun 2022 | - | $64.63 M(-4.8%) |
| Mar 2022 | - | $67.91 M(-3.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | $70.08 M(-2.1%) | $70.08 M(-22.1%) |
| Sep 2021 | - | $89.93 M(+2.9%) |
| Jun 2021 | - | $87.37 M(+19.2%) |
| Mar 2021 | - | $73.27 M(+2.4%) |
| Dec 2020 | $71.57 M(+31.5%) | $71.57 M(-63.8%) |
| Sep 2020 | - | $197.50 M(+263.0%) |
| Dec 2019 | $54.41 M | $54.41 M |
FAQ
- What is Chinook Therapeutics annual total long term liabilities?
- What is the all time high annual total long term liabilities for Chinook Therapeutics?
- What is Chinook Therapeutics annual total long term liabilities year-on-year change?
- What is Chinook Therapeutics quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Chinook Therapeutics?
- What is Chinook Therapeutics quarterly long term liabilities year-on-year change?
What is Chinook Therapeutics annual total long term liabilities?
The current annual total long term liabilities of KDNY is $81.31 M
What is the all time high annual total long term liabilities for Chinook Therapeutics?
Chinook Therapeutics all-time high annual total long term liabilities is $81.31 M
What is Chinook Therapeutics annual total long term liabilities year-on-year change?
Over the past year, KDNY annual total long term liabilities has changed by +$11.23 M (+16.03%)
What is Chinook Therapeutics quarterly total long term liabilities?
The current quarterly long term liabilities of KDNY is $79.30 M
What is the all time high quarterly long term liabilities for Chinook Therapeutics?
Chinook Therapeutics all-time high quarterly total long term liabilities is $197.50 M
What is Chinook Therapeutics quarterly long term liabilities year-on-year change?
Over the past year, KDNY quarterly total long term liabilities has changed by +$14.67 M (+22.70%)